Skip to main content
Premium Trial:

Request an Annual Quote

Danaher Initiates EPS Guidance for 2015

NEW YORK(GenomeWeb) — Danaher today initiated guidance for adjusted diluted EPS for 2015 in the range of $4.35 to $4.45. 

The guidance assumes core revenue growth of 3 percent to 4 percent and excludes anticipated non-cash amortization for 2015 of $440 million, or $.46 per share, compared to about $380 million, or $40 per share, in 2014.  

The company also reaffirmed GAAP diluted EPS for the fourth quarter of 2014 to be in the range of $1 to $1.04. 

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.